Are Pfizer leaving them? Seems likely from the attached job posting. A bold move, for sure, but one can only assume there is confidence that change is necessary to leave yesterdays technology constraints, and embrace tomorrows opportunities.
OPUS is delayed 3 years! Should OPUS be a free upgrade to all existing customers? Will it be their MAGNUM OPUS or NOPUS or FLOPUS?
The current interface is somewhat fragmented and old fashioned, and not the best possible user experience. It lacks an order management based interface, and segregates data in the most unusual ways.
There is nowhere you can report or query multiple batches to detail – It is the proverbial Fischer Price of level 4 interfaces, scores very low for Data Analysis, Integration and Management when compared to EU vendor solutions from tracekey solutions GmbH – The No. 1 for small and mid-sized businesses to SAP.
Let us also examine the already puzzling and peculiar model of TraceLink Network Service Management…Do customers really benefit from NSM Services to manage non TraceLink customers connections…Why don’t they manage all customer connections?
2 areas of interest of NSM are System Constraint and Anti-Competition. However, we will share more about these topics in our new Points Of View webpage coming to Ankhero this Autumn.
Ankhero encourages Pharma Companies to review other vendors on a yearly basis. Software and Services should increase in value and deliver cost opportunity over time…not the opposite.